Cargando…
CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene
BACKGROUND: The antithyroid thioureylenes, propylthiouracil (PTU) and methimazole (MMI), are effective in the treatment of patients with plaque psoriasis. The mechanism of action of the drugs in psoriasis is unknown. Since the drugs reduce circulating IL-12 levels in patients with Graves' hyper...
Autores principales: | Elias, Alan N, Nanda, Vandana S, Barr, Ronald J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC169161/ https://www.ncbi.nlm.nih.gov/pubmed/12841851 http://dx.doi.org/10.1186/1471-5945-3-3 |
Ejemplares similares
-
Serum TNF-α in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene
por: Elias, Alan N, et al.
Publicado: (2004) -
Mode of binding of the antithyroid drug propylthiouracil to mammalian haem peroxidases. Erratum
por: Singh, R. P., et al.
Publicado: (2015) -
Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia
por: Mengistu, Habtamu Solomon, et al.
Publicado: (2022) -
Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose()
por: Arul, Santhosh, et al.
Publicado: (2016) -
Propylthiouracil-Induced Skin Vasculitis
por: Almeida, Mariana S, et al.
Publicado: (2022)